BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38170674)

  • 1. Physiological Characterization of Preserved Ratio Impaired Spirometry in the CanCOLD Study: Implications for Exertional Dyspnea and Exercise Intolerance.
    Phillips DB; James MD; Vincent SG; Elbehairy AF; Neder JA; Kirby M; Ora J; Day AG; Tan WC; Bourbeau J; O'Donnell DE;
    Am J Respir Crit Care Med; 2024 Jun; 209(11):1314-1327. PubMed ID: 38170674
    [No Abstract]   [Full Text] [Related]  

  • 2. Low resting diffusion capacity, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease.
    Elbehairy AF; O'Donnell CD; Abd Elhameed A; Vincent SG; Milne KM; James MD; Webb KA; Neder JA; O'Donnell DE;
    J Appl Physiol (1985); 2019 Oct; 127(4):1107-1116. PubMed ID: 31369329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary Gas Exchange Abnormalities in Mild Chronic Obstructive Pulmonary Disease. Implications for Dyspnea and Exercise Intolerance.
    Elbehairy AF; Ciavaglia CE; Webb KA; Guenette JA; Jensen D; Mourad SM; Neder JA; O'Donnell DE;
    Am J Respir Crit Care Med; 2015 Jun; 191(12):1384-94. PubMed ID: 25826478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease.
    Ofir D; Laveneziana P; Webb KA; Lam YM; O'Donnell DE
    Am J Respir Crit Care Med; 2008 Mar; 177(6):622-9. PubMed ID: 18006885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired Ventilatory Efficiency, Dyspnea, and Exercise Intolerance in Chronic Obstructive Pulmonary Disease: Results from the CanCOLD Study.
    Phillips DB; Elbehairy AF; James MD; Vincent SG; Milne KM; de-Torres JP; Neder JA; Kirby M; Jensen D; Stickland MK; Guenette JA; Smith BM; Aaron SD; Tan WC; Bourbeau J; O'Donnell DE;
    Am J Respir Crit Care Med; 2022 Jun; 205(12):1391-1402. PubMed ID: 35333135
    [No Abstract]   [Full Text] [Related]  

  • 6. Excess Ventilation in Chronic Obstructive Pulmonary Disease-Heart Failure Overlap. Implications for Dyspnea and Exercise Intolerance.
    Rocha A; Arbex FF; Sperandio PA; Souza A; Biazzim L; Mancuso F; Berton DC; Hochhegger B; Alencar MCN; Nery LE; O'Donnell DE; Neder JA
    Am J Respir Crit Care Med; 2017 Nov; 196(10):1264-1274. PubMed ID: 28665692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resting Physiological Correlates of Reduced Exercise Capacity in Smokers with Mild Airway Obstruction.
    Elbehairy AF; Faisal A; Guenette JA; Jensen D; Webb KA; Ahmed R; Neder JA; O'Donnell DE;
    COPD; 2017 Jun; 14(3):267-275. PubMed ID: 28368706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of exertional dyspnoea in symptomatic smokers without COPD.
    Elbehairy AF; Guenette JA; Faisal A; Ciavaglia CE; Webb KA; Jensen D; Ramsook AH; Neder JA; O'Donnell DE;
    Eur Respir J; 2016 Sep; 48(3):694-705. PubMed ID: 27492828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of dynamic hyperinflation on exertional dyspnea, exercise performance and quality of life in COPD].
    Ozgur ES; Atis S; Kanik A
    Tuberk Toraks; 2008; 56(3):296-303. PubMed ID: 18932031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exertional dyspnoea in patients with mild-to-severe chronic obstructive pulmonary disease: neuromechanical mechanisms.
    James MD; Phillips DB; Vincent SG; Abdallah SJ; Donovan AA; de-Torres JP; Neder JA; Smith BM; Jensen D; O'Donnell DE;
    J Physiol; 2022 Sep; 600(18):4227-4245. PubMed ID: 35861594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once-daily NVA237 improves exercise tolerance from the first dose in patients with COPD: the GLOW3 trial.
    Beeh KM; Singh D; Di Scala L; Drollmann A
    Int J Chron Obstruct Pulmon Dis; 2012; 7():503-13. PubMed ID: 22973092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The continuum of physiological impairment during treadmill walking in patients with mild-to-moderate COPD: patient characterization phase of a randomized clinical trial.
    O'Donnell DE; Maltais F; Porszasz J; Webb KA; Albers FC; Deng Q; Iqbal A; Paden HA; Casaburi R;
    PLoS One; 2014; 9(5):e96574. PubMed ID: 24788342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant Spirometric Transitions and Preserved Ratio Impaired Spirometry Among Ever Smokers.
    Wan ES; Hokanson JE; Regan EA; Young KA; Make BJ; DeMeo DL; Mason SE; San Jose Estepar R; Crapo JD; Silverman EK
    Chest; 2022 Mar; 161(3):651-661. PubMed ID: 34592319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preserved ratio impaired spirometry is associated with small airway dysfunction and reduced total lung capacity.
    Zhao N; Wu F; Peng J; Zheng Y; Tian H; Yang H; Deng Z; Wang Z; Li H; Wen X; Xiao S; Huang P; Dai C; Lu L; Zhou K; Chen S; Zhou Y; Ran P
    Respir Res; 2022 Oct; 23(1):298. PubMed ID: 36316732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decline of resting inspiratory capacity in COPD: the impact on breathing pattern, dyspnea, and ventilatory capacity during exercise.
    O'Donnell DE; Guenette JA; Maltais F; Webb KA
    Chest; 2012 Mar; 141(3):753-762. PubMed ID: 21852298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiological predictors of morbidity and mortality in COPD: the relative importance of reduced inspiratory capacity and inspiratory muscle strength.
    Phillips DB; James MD; O'Donnell CD; Vincent SG; Webb KA; de-Torres JP; Neder JA; O'Donnell DE
    J Appl Physiol (1985); 2022 Sep; 133(3):679-688. PubMed ID: 35952349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical relevance of fixed ratio vs lower limit of normal of FEV1/FVC in COPD: patient-reported outcomes from the CanCOLD cohort.
    van Dijk W; Tan W; Li P; Guo B; Li S; Benedetti A; Bourbeau J;
    Ann Fam Med; 2015; 13(1):41-8. PubMed ID: 25583891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and Characteristics of Individuals with Preserved Ratio Impaired Spirometry (PRISm) and/or Impaired Lung Function in Japan: The OCEAN Study.
    Kaise T; Sakihara E; Tamaki K; Miyata H; Hirahara N; Kirichek O; Tawara R; Akiyama S; Katsumata M; Haruya M; Ishii T; Simard EP; Miller BE; Tal-Singer R
    Int J Chron Obstruct Pulmon Dis; 2021; 16():2665-2675. PubMed ID: 34588775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined effects of obesity and chronic obstructive pulmonary disease on dyspnea and exercise tolerance.
    Ora J; Laveneziana P; Ofir D; Deesomchok A; Webb KA; O'Donnell DE
    Am J Respir Crit Care Med; 2009 Nov; 180(10):964-71. PubMed ID: 19897773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease.
    Marin JM; Carrizo SJ; Gascon M; Sanchez A; Gallego B; Celli BR
    Am J Respir Crit Care Med; 2001 May; 163(6):1395-9. PubMed ID: 11371407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.